Clinical Trials Browser

Phase 2 × Not yet recruiting × tafasitamab × Clear all

NCT07502872 2026-03-31

TPG

Phase 2 Not yet recruiting

Lymphoma, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse